Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kung-Long Ocean Biotechnology is a Taiwan-based marine biotechnology company specializing in the extraction and application of deep-sea water (DSW) minerals. The company utilizes advanced filtration and concentration technologies to produce mineral-rich ingredients for the healthcare, cosmetic, and food industries. Their research focuses on the therapeutic potential of deep-sea minerals in addressing metabolic syndrome, cardiovascular health, and dermatological conditions. Kung-Long Ocean Biotechnology operates a dedicated manufacturing facility in Hualien, sourcing water from depths exceeding 600 meters. The company's product portfolio includes mineral concentrates, health supplements, and specialized skincare formulations. By collaborating with academic institutions, they aim to provide scientifically validated marine-derived solutions for global wellness markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kung-Long Ocean Biotechnology.